GlassScriptPhysician profile
Jason Jedlicka
NPI 1669484622
$456,053.02
in general payments reported to CMS, 2019-2025
11 companies · $70K in 2025
The $70K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $40K · 2021: $51K · 2022: $92K · 2023: $93K · 2024: $56K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $118K · Consulting Fee: $58K · Travel and Lodging: $27K · Honoraria: $13K · Food and Beverage: $2,832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $118,225.00 |
| Consulting Fee | $57,504.64 |
| Travel and Lodging | $26,989.52 |
| Honoraria | $13,000.00 |
| Food and Beverage | $2,831.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $286,761.27 | 2022-2025 | Zenlens, Alden Scleral Zenlens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $127,664.50 | 2019-2021 | |
| Oculus, INC. | $37,507.13 | 2019-2025 | Myopia Master, Pentacam, Pentacam Axl Wave |
| Valley Contax, INC. | $1,500.00 | 2021 | |
| Visionary Optics LLC | $920.00 | 2019-2022 | |
| Glaukos Corporation | $778.77 | 2021-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Kxl System |
| Sun Pharmaceutical Industries INC. | $353.32 | 2022-2024 | Cequa |
| Alcon Vision LLC | $231.84 | 2025 | |
| Coopervision INC. | $198.32 | 2019-2025 | Onefit Contact Lens |
| Dompe US, INC. | $125.00 | 2020 | |
| Allergan, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jedlicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.